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Interleukin-2 (IL-2) is a potent growth factor that mature T lymphocytes synthesize and
use as a proliferation signal. Much controversy has arisen concerning whether it is used
to drive the extensive proliferation of immature pre-T cells in the thymus. Immature
thymocytes acquire the competence to express IL-2 at an early stage, but it has remained
uncertain whether they are activated to exercise this competence in vivo. Therefore, we
have used in situ hybridization and immunohistochemistry on serial sections obtained
from fetal and adult thymuses of normal C57BL/6 mice and of mice bearing the scid
defect to determine where, when, and whether IL-2 is expressed in vivo. Our results
show a striking spatial and temporal pattern of IL-2 expression in the normal fetal
thymus. We detected a burst of IL-2 mRNA accumulation at day 14.5 of gestation, which
rapidly decreased by day 15. At day 15, we observed maximal IL-2 protein production
that subsequently decreased by day 16 of gestation. Both in situ hybridization and
immunohistochemical staining revealed an unexpectedly strict localization of IL-2
expressing cells to patches around the periphery of the fetal thymus, creating a
previously unrecognized compartment of high IL-2 protein content. IL-2 production in
the day-15 fetal thymus appeared to be unaffected by the scid mutation, indicating that
this response is likely to be T-cell receptor (TcR)-independent. Several features
distinguish the IL-2 induction pattern in the adult thymus from that in the fetal thymus.
In the normal adult thymus, IL-2-expressing cells are extremely rare (found at a
frequency of 10-7), but they are reproducibly detectable as isolated cells in the outer
cortex and subcapsular region of the thymus. Unlike the fetal thymic IL-2 producers, the
IL-2 producers in the adult thymus are completely eliminated in mice homozygous for
the scid mutation. This suggests that the IL-2-expressing cells in the normal adult
thymus are of a more mature phenotype than the immature, TcR-negative cells that
accumulate in the scid adult thymus. Thus, our work demonstrates that two
developmentally distinct types of cell interactions induce IL-2 expression in vivo: one, a
broadly localized interaction in day 14-15 fetal thymus that is unaffected by the scid
mutation; the other, a rare event that occurs asynchronously from late fetal through
adult life, but which is completely eliminated by the scid defect. These results imply that
significant differences exist between the physiological processing of thymocytes in the
fetal and postnatal thymic microenvironments.
KEYWORDS: Interleukin-2 (IL-2), interleukin-2 receptor (IL-2R), thymus, in situ hybridization, immunohistochemistry, severe
combined immunodeficiency (scid), T-cell receptor (TcR).
INTRODUCTION
T cells, unlike other cell types of the hemato-
poietic lineage, differen.tiate in the thymus,
*Corresponding author.
where differentiation is accompanied by exten-
sive proliferation, apparently triggered by
mitotic signals from the thymic stroma. Thymus-
specific lymphostromal interactions are critical
for driving T-cell development, yet both the
nature of the signals and the molecular basis of
their impact remain unknown. Among the
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properties acquired and modulated as thymo-
cytes develop is the competence to express
"response" genes that drive proliferation in
mature T cells, such as the gene encoding the
potent growth factor interleukin-2 (IL-2)
(McGuire and Rothenberg, 1987; Howe and Mac-
Donald, 1988; Rothenberg et al., 1988; Tentori et
al., 1988b; Fischer et al., 1991; Chen and Rothen-
berg, 1993). Although the inducibility of these
genes at certain stages of differentiation is easily
demonstrable under artificial conditions in vitro,
it is not known whether intrathymic signals pro-
vide inductive stimuli for these genes in vivo.
Thus, it is unclear to what extent growth factors
such as IL-2 are normally available to contribute
to the hormonal microenvironment of the thy-
mus. Similarly, it has remained uncertain
whether the characteristic signaling pathways
that activate IL-2 expression in vitro are utilized
in normal thymocyte development in vivo.
Recent gene-disruption experiments have for-
mally proven that IL-2 is not required for the
generation of normal cell populations in the thy-
mus (Schorle et al., 1991). However, severe per-
turbations can be induced in thymocyte develop-
ment, in vivo or in organ culture, by anti-IL-2R
antibody treatment (Jenkinson et al., 1987; Ten-
tori et al., 1988a; Zuiga-Pfliicker and Kruisbeek,
1990; Zuiga-PfliJcker et al., 1990), by the
addition of excess IL-2 (Skinner et al., 1987; Plum
and de Smedt, 1988; Waanders and Boyd, 1990),
or by the introduction of a transgenic IL-2Rc
chain with inappropriate species specificity
(Kroemer et al., 1991). Thus, the possibility
remains that IL-2 production in vivo plays some
developmental role. Furthermore, studies from
our own laboratory and from others have shown
that the intrinsic competence to express the IL-2
gene is shared by both mature and immature thy-
mocytes (Howe and MacDonald, 1988; Rothen-
berg et al., 1990; Fischer et al., 1991). However, it
is unknown whether the thymic microenviron-
ment can actually provide signals to induce IL-2
expression in either or both populations of thym-
ocytes. Therefore, IL-2 production (1) could
potentially be induced at any of several stages in
vivo and (2) might cause autocrine or paracrine
effects, either early or late in T-cell development.
These issues make it instructive to determine the
conditions under which developing thymocytes
actually exercise their competence to express IL-2
in vivo.
Several laboratories have analyzed cytokine
expression during fetal thymocyte development
in vivo as an approach to determine which factors
might be present in the thymus during T-cell
development. Von Boehmer and coworkers
initially reported that IL-2 is secreted as fetal thy-
mocytes mature in organ culture (Kisielow et al.,
1985). Subsequent studies have shown that
murine embryonic thymocytes harvested at dif-
ferent times during gestation express a variety of
cytokine mRNAs, using either in situ hybridiz-
ation to cytocentrifuged preparations of freshly
isolated cells (Carding et al., 1989, 1990; Zufiiga-
Pfliacker et al., 1990) or reverse transcription/
polymerase chain reaction (rtPCR) analysis of
total RNA samples obtained from fetal thymuses
(Montgomery and Dallman, 1991). Most of these
studies have focused exclusively on dissociated
cell suspensions, making localization and identi-
fication of the IL-2-expressing cells within the
thymus impossible. On a more general level,
these studies have failed to distinguish between
the developmental events involved in the fetal
ontogeny of the thymus itself and those involved
in the maturation of T-cell precursors processed
therein. In adult animals, thymocyte develop-
ment generates a different spectrum of T-cell sub-
types than that generated during thymocyte
development in the fetus (reviewed in Rothen-
berg, 1992). This could be attributable either to
differences in the thymic environment or to the
difference in hematopoietic origins between the
precursors that seed the fetal and the postnatal
thymus (Ikuta et al., 1990). Thus, it is
not clear whether IL-2 production is a universal
feature of T-cell development or a peculiarity
of the cell types present in the fetal
thymus.
In order to examine the spatial and temporal
pattern of IL-2 gene expression as induced nat-
urally during T-cell ontogeny in vivo, we have
used a combination of in situ hybridization and
immunohistochemical staining of mouse thymus
sections isolated at different stages of develop-
ment. Our findings show different and distinc-
tive patterns of IL-2 gene expression in fetal ver-
sus adult thymuses. Additionally, IL-2 gene
expression appears to be normal in the fetal thy-
mus but perturbed in the adult thymus of ani-
mals that cannot generate mature T cells as a
result of the severe combined immunodefficiency
(scid) mutation.
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RESULTS
Developmental Pattern of IL-2 Gene
Expression in the Fetal Thymus as Determined
by In Situ Hybridization
Figure 1 shows the patterns of IL-2-specific
hybridization in the murine fetal thymus at dif-
ferent stages of gestation as defined using 590 nt
antisense or sense riboprobes. At day 14, a few
highly positive cells were found, mainly in the
outer region of the thymus (Fig. 1A). At day 14.5,
the outer region of the thymus contained a dra-
matically increased number of highly positive
cells, clustered in distinctive, large patches of
hybridization one cell deep that "outlined" the
periphery of the tissue (Fig. 1C). At this stage of
gestation, no corticomedullary boundary was
observed in the thymus; cells appeared equally
distributed throughout the organ (Figs. 1C and
1D). Although the majority of sections of day 14.5
fetal thymus did not include any regions of
strong hybridization, every thymus examined
contained sections exhibiting this striking localiz-
ation of highly positive cells. By day 15, the per-
centage of IL-2 mRNA positive cells decreased,
and only an occasional highly positive cell was
found (6-8 per half lobe equivalent; Fig. 1E). Iso-
lated positive cells were also observed later, at
day 18 of gestation, and distinct cortical and
medullary regions w.ere identifiable by this time
by DAPI staining (data not shown). The remain-
ing IL-2 mRNA positive cells in the fetal thymus
at later stages of gestation were still restricted to
the cortex and not to the medulla. Thus, highly
positive IL-2 mRNA-expressing cells were pre-
sent at day 14 of gestation in the fetal thymus and
some highly positive cells persisted through day
18 of gestation. However, a dramatic peak of
highly localized IL-2 gene expression was
observed at day 14.5, which decreased abruptly
by day 15.
Pattern of IL-2 Expression in the Fetal Thymus
at Different Stages of Development by
Immunohistochemistry
To confirm the pattern of IL-2 expression as
determined from the in situ hybridization data,
fetal thymuses isolated dt various stages of ges-
tation were also stained with an anti-IL-2 mAb
(Fig. 2). At day 14-14.5, weak immunoreactivity
was observed (Fig. 2A; data not shown). At day
15, strong staining appeared in the outer region
of the tissue (Fig. 2C). This staining pattern was
not seen when normal rat IgG was substituted for
the anti-IL-2 mAb (Fig. 2D); the IL-2 specificity of
the staining reagent was further confirmed by
control experiments with excess rmuIL-2 (see
below). At day 16, immunoreactivity was still
present around the periphery of the thymus,
albeit at a reduced level (Fig. 2E), and at day 18,
only isolated immunoreactive cells were found in
the cortical region. A background of endogenous
peroxidase-positive cells became detectable by
day 18 (data not shown), but these cells could be
distinguished from IL-2 immunoreactive cells by
prior blocking and peroxidase quenching (for
additional controls, see below). Nonetheless,
based on these characteristics, the pattern of IL-2
protein expression, detected by immunohistoch-
emistry, recapitulated the pattern of IL-2 mRNA
accumulation as determined by in situ hybridiz-
ation. Additionally, maximum IL-2 protein
expression was observed 12 hr following maxi-
mum IL-2 mRNA accumulation.
Vy3 and CD16 Expression versus IL-2
Expression in Day 15 Fetal Thymus as
Determined by Immunohistochemistry
IL-2 has been implicated in the growth of Vy3+ T
cells and natural killer (NK) cells from the fetal
thymus in vitro (Skinner et al., 1987; LeClerq et
al., 1990). Therefore, we were interested in
determining whether intrathymic IL-2 was
associated with the generation or expansion of
particular subsets of T cells or NK cells in the
fetal thymus in vivo. By day 15 of gestation,
almost all of the rare thymocytes expressing sur-
face TcR specifically utilize the Vy3 segment in
TcR gene rearrangements (Havran and Allison,
1988). Likewise, the majority of cells in the fetal
thymus at day 15 of gestation express CD16
(FcRII/III; Rodewald et al., 1992), a marker that
persists preferentially on pre-NK and NK cells.
We used a Vy3-specific (536) or CD16-specific
(2.4G2) mAb along with the IL-2-specific mAb for
immunohistochemical staining of adjacent serial
sections of day 15 fetal thymus to determine the
relative location of V,3+ and CD16/ cells with
respect to IL-2-producing cells (Fig. 3). At this
stage of gestation, the majority of the cells in the
fetal thymus were cytoplasmic CD3e+ (data not
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shown). CD16/ cells were detected in a hetero-
geneous distribution throughout the fetal thy-
mus. V’3+ cells were also detectable in a similar
distribution (Fig. 3), but were substantially less
abundant than CD16/ cells. Neither cell type was
concentrated in the peripheral region of the lobe.
Thus, these results gave no clear evidence for
colocalization of IL-2-producing cells with either
V’3 or CD16 expression (see Discussion).
IL-2 Expression in the Scid Day 15 Fetal Thymus
Mice homozygous for the scid mutation fail to
rearrange their TcR genes normally, causing a
developmental arrest that blocks the production
of all classes of TcR/ thymocytes (Bosma and
Carroll, 1991). In order to determine whether the
scid defect affected IL-2 expression in the fetal
thymus, we used immunohistochemistry to
detect IL-2-producing cells in the scid day 15 fetal
thymus (Figs. 2I to 2L). Scid day 15 fetal thy-
muses appeared normal in terms of the intensity
and localization of IL-2 immunoreactivity (Fig.
2I). This staining was also shown to be IL-2-
specific. When an excess of exogenous recombi-
nant IL-2 was added, IL-2 immunoreactivity was
abolished (Figs. 2K and 2L); as a control, addition
of recombinant IL-4 had little effect (data not
shown). Likewise, the gross architecture and size
of the scid day 15 fetal thymus appeared to be
normal in terms of cell density and number (data
not shown). In situ hybridization of scid day 15
fetal thymus sections revealed that a similar
number of highly labeled IL-2 mRNA positive
cells were present as compared to the normal
counterpart (data not shown). Hence, at this
stage of gestation, TcR rearrangement and
expression are not prerequisites for IL-2
expression in vivo.
Analysis of IL-2Rc expression confirmed the
lack of gross perturbation of thymocyte develop-
ment in scid mice at this age. When sections were
stained with a rat anti-mouse IL-2Ro mAb, nor-
mal and scid day 15 fetal thymuses were similar
with regard to the number and distribution of IL-
2Ro+ cells in the thymus (Figs. 4A and 4B). By
contrast, differences were readily apparent when
comparing the IL-2Rc staining pattern of the nor-
mal versus scid adult thymus. The overwhelming
majority of the cells in all regions of the scid adult
thymus are IL-2Rc+, as compared with the
irregular clusters of IL-2Rc+ cells in the cortex of
the normal tissue (Figs. 4C and 4D). This aberrant
IL-2Rc staining pattern of the scid adult thymus
convincingly showed the developmental arrest-
blocking progression beyond the IL-2Rc+ imma-
ture stage. These staining results indicated that
the scid mutation did not severely affect the con-
trol of IL-2 or IL-2Rc expression in the fetal thy-
mus, in spite of its severe developmental effects
observed in the adult thymus.
In Situ Hybridization of Normal Adult Thymus
Sections
In previous analyses of cytocentrifuged prep-
arations of adult thymus cell suspensions, we
had failed to detect any cells expressing IL-2
mRNA (McGuire and Rothenberg, 1987; Rothen-
berg et al., 1990). Ribonuclease protection assays
failed to detect any IL-2 transcripts in samples of
up to 100/g of adult thymus total RNA, roughly
equivalent to the amount of RNA isolated from
half a thymic lobe (400tg total RNA/thymus;
data not shown). However, the results of four
independent experiments confirmed the presence
of extremely rare, highly labeled IL-2 mRNA-
positive cells in the thymus of 4-week-old mice.
Approximately 160 sections hybridized alter-
nately with each strand of the 430-nt probe were
analyzed per experiment (approximately 320 sec-
tions examined overall, corresponding to a thy-
mus lobe; i.e., a half lobe equivalent for each
probe). Highly labeled cells were found only in
sections that had been hybridized with the anti-
sense riboprobe. These IL-2-positive cells were
reproducibly found in the outer cortex and sub-
capsular region of the thymus (Fig. 5A); the corti-
cal versus medullary regions of the thymus were
distinguished by higher or lower cell density
within the section, as shown by DAPI staining
(Figs. 4A and 4B). Surprisingly, of all the IL-2-
FIGURE 1. (See Colour Plate VI at the back of this publication). In situ hybridization to sections of normal thymuses from days
14 to 18 of gestation for IL-2 expression, using either a 35S-labeled, 590-nt IL-2 antisense I.NA probe (IL-2; Figs. 1A, 1C, 1E, 1G) or
the complementary sense strand (NC; Figs. 1B, 1D, 1F, 1H). Samples were counterstained with DAPI and observed under dark
field microscopy. 14-day exposure; magnification x200.
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TABLE
Titration of 430-nt 3’-IL-2 Probe by Ribonuclease A, T1 Protection Using Total RNA Isolated from Induced EL4 Ceils
% induced % IL-2 No. copies No. copies No. copies No. copies
EL4 mRNA IL-2 IL-2 per IL-2 per IL-2 per
by in situ protected avg. cell induced cell mRNA cell
1 0.64 1.5xl 06 1.5 150 234
2 1.4 2.9x106 2.9 145 207
5 3.4 7.1 xl06 7.1 140 206
10 8.1 1.8xl07 18 180 222
20 13.9 3.3x107 33 165 240
50 35.0 7.9x107 79 160 229
100 74.0 1.Txl08 170 170 230
The average number of copies IL-2 per IL-2 mRNA ce11=224+18
aEL4 cells induced for hr with calcium ionophore and phorbol ester mixed with uninduced EL4 cells at the percentages indicated (a total of 5x106 viable cell
equivalents per sample).
Total RNA extracted according to the method described by Chomczynski and Sacchi (1987).
One-fifth of each sample (or RNA from lx106 cell equivalents) was used per protection. No protection was observed above background using total RNA isolated from
uninduced EL4 cells.
bIdentical samples of cells processed described in Materials and Methods and analyzed by in situ hybridization. Signals from at least 5000 cells analyzed per
sample.
’No. copies protected conversion factor phosphor imaser value for protected product
cpm undigested probe used per protection
ng probe used per protection 6 1023 molecules per mole
molec, wt. protected product
where the conversion factor (liquid scintillation cpm determined for known amounts of undigested probe.
phosphor imager value)’
No. copies IL-2 protected
106
No. copies IL-2 per avg. cell
% ind. EL4 10
No. copies IL-2 per ind. cell % induced EL4
%IL-2 mRNA by in situ
least 100-fold for immature thymocytes at all
stages leading up to the CD3-CD4-CD8- (TN) IL-
2Rc/ stage of development (see Fig. 4) (Bosma
and Carroll, 1991). If the IL-2 mRNA-
positive/immunoreactive cells in the thymus of
normal animals were of an immature phenotype,
they should be present in greater numbers in the
scid adult thymus than in the normal counterpart.
On the other hand, if these cells had matured
past the stage of TcR gene rearrangement, they
should be depleted in the scid adult thymus. In
situ hybridization revealed that IL-2 mRNA-posi-
tive cells were conspicuously absent from the scid
adult thymus; both antisense and sense probes
gave identical results in all sections analyzed
(Figs. 5D and 5E). The absence of hybridization
in the scid adult thymus samples was not due to
artifactual degradation of probes hybridized to
the scid thymus sections, because alternate sec-
tions hybridized with IL-2Rc antisense probes
yielded strong signals (Fig. 5F), consistent with
the results obtained from direct immunofluoresc-
ent staining (Fig. 4D).
For direct quantitative comparison, hybridiz-
ation of scid thymus sections were carried out in
parallel with hybridization of normal thymus
sections (Fig. 6). On average, fewer sections per
scid thymus were analyzed than per normal thy-
mus because scid adult thymuses were substan-
tially smaller than normal adult thymuses (scid
thymuses, which lack all TcR/ cell types, contain
approximately 1/100 the number of viable cells
found in normal thymuses; data not shown). Due
to the reduced cell numbers in the scid adult thy-
mus, the frequency of IL-2-expressing cells could
not be proven to be lower in the scid adult thy-
mus than in the normal adult thymus on a p_
cell basis. Nonetheless, the depletion of IL-2
mRNA-positive cells per lobe in the scid thymus
was highly significant (Fig. 6).
The absence of cells producing IL-2 protein in
the scid adult thymus was difficult to confirm by
immunohistochemistry due to a high back-
ground of endogenous, peroxidase-positive cells
that were "reactive" in the absence of specific
antibody, even after extensive H202/peroxidase
quenching (data not shown). Nevertheless, based
on the unambiguous in situ hybridization data, it
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Normal scid
Average Number of Sections Hybridized with Either Strand: Normal=162
scid 80
Average Number of Sections Analyzed per Experiment: Normal=324
scid =160
FIGURE 6. Compiled data of in situ hybridization for IL-2
expression in adult thymus from normal and scid mice. Adult
thymus sections from normal and scid animals (open and
shaded points, respectively) were analyzed by in situ
hybridization with the 430-nt antisense or sense IL-2 RNA
probe. Approximately half a thymic lobe was hybridized with
each probe. The results using the antisense probe were
compiled from four independent experiments. No signals were
detected with the sense probe (data not shown). Normal and
scid sections hybridized and analyzed in parallel are denoted
with identical shapes (circles, diamonds). Positive cells were
considered as having greater than 10 silver grains. The
average, total numbers of sections analyzed per normal and
scid thymus were 320 and 80, respectively, corresponding to
complete thymic lobes. Slides were exposed for 21 days.
appeared that IL-2 mRNA-positive cells in the
normal adult thymus were very likely to be of a
more mature phenotype than the developmen-
tally arrested thymocytes found in the scid adult
thymus.
DISCUSSION
Our results show that IL-2 expression is induced
in thymocytes by intrathymic signals in vivo. This
expression is subject to complex developmental
regulation that constrains the possible roles of IL-
2 as a mediator of signals. On the other hand, the
induction of IL-2 itself serves as a probe for
specific cell-cell interactions, which reveal sur-
prising differences between the fetal and adult
thymus.
Restricted Activation of IL-2 Expression in the
Fetal Thymus
Our results show that the day 15-16 fetal thymus
includes distinct, substantial zones of low and
high regional IL-2 protein concentration, in good
agreement with the results of Waanders (1990).
Twelve hours prior to maximal protein pro-
duction, a burst of IL-2 message accumulation is
observed in cells restricted to the identical area
where IL-2 protein will be found, namely, the
periphery of the fetal thymus. The combined in
situ hybridization and immunohistochemical
staining data reported here for day 14.5-15 fetal
thymus show that only a minority of the cells in
the fetal thymus were expressing IL-2 message or
protein at the given time points. This interpret-
ation is not in complete agreement with that of
Zufiiga-Pflficker et al. (1990), who reported that
50-60% of fetal thymocytes expressed IL-2
mRNA at day 15 gestation, based on in situ
hybridization to cytocentrifuged samples. The
disparity in percentage of IL-2 mRNA-positive
cells could be due to any of several factors.
Because the kinetics of IL-2 expression are clearly
transient, our time points might have missed the
true peak. Alternatively, the timing of the actual
impregnation of the mice could be affected by the
setting of the 12-hr light-dark cycle in the
respective mouse colonies, leading to apparent
shifts in kinetics. Also, in principle, there could
be a lower threshold of detection for in situ
hybridization to cytocentrifuged cell suspensions
than to tissue sections. Finally, as Zufiiga-
Pfliicker et al. (1990) did not subdivide categories
of IL-2 mRNA-positive cells based on silver grain
count, they might have included cells that we
would not consider to be unequivocally IL-2-
positive. However, our immunohistochemical
staining data support our in situ hybridization
results, indicating that only a highly localized
minority population express IL-2 protein that is
detectable at days 15-16 of gestation. Thus,
according to these staining results, if 50-60% of
cells do express an IL-2 message at the time of
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our terminology) grown in moderate amounts of
IL-2 (Rodewald et al., 1992). Furthermore, trans-
genic mice constitutively expressing IL-2 and IL-
2Ro chain show great preferential expansion of
NK cells (Ishida et al., 1989). Based on these data,
the generation of either of these cell types in the
fetal thymus in vivo could be positively regulated
by the local concentration of IL-2. However,
when we examined V,3, CD16, and IL-2
expression in the day 15 fetal thymus by
immunohistochemical staining, we were unable
to show a relationship between the localization of
V,3+ or CD16/ cells and IL-2 producers (Fig. 4).
Although we cannot formally disprove the possi-
bility that V,3- or CD16- precursors of either cell
type respond to IL-2, these results make it
unlikely that IL-2 is limiting for the generation of
Vy3/ T cells or CD16/ cells (presumptive T/NK
precursors) in the fetal thymus in vivo. The tar-
gets for the burst of fetal IL-2 production there-
fore remain undefined.
In contrast to the results obtained from day
14.5-15 fetal thymuses, IL-2-expressing cells are
extremely rare in the adult thymus with a fre-
quency on the order of 10-7 as determined by
both in situ hybridization and immunohisto-
chemical staining. Any cells responding to IL-2 in
the adult thymus in vivo would most likely need
to be in close proximity to these IL-2 producers,
based on the minimal diffusion of IL-2 protein
observed in the cortex. Unlike IL-2 production in
the fetal thymus, no continuous zones of high IL-
2 concentration are found in the adult organ. Fur-
thermore, IL-2 may be available in these local
sites for only a limited time. Our data suggest
that the steady-state frequency of IL-2-expressing
cells reflects the asynchronous activation of dif-
ferent rare cells. In the adult thymus, cells pro-
ducing IL-2 protein were detected at an approxi-
mately threefold higher frequency than cells
expressing IL-2 mRNA at any one time. The IL-2
mRNA is known to be labile (Shaw et al., 1988;
Lindsten et al., 1989), and our results with the
fetal thymus indicate that IL-2 protein can persist
in the thymus at least 1 day longer than IL-2
mRNA. Thus, we interpret the excess of IL-2
immunoreactive cells over IL-2 mRNA-positive
cells as evidence that IL-2 gene induction in the
adult thymus is also transient but asynchronous;
that is, that most cells synthesizing IL-2 protein
have already shut off synthesis of the short-lived
IL-2 mRNA. When the resulting limited avail-
ability of IL-2 is compared with the 10-20% of
thymocytes that are actively in cycle (Penit, 1986;
Boyer et al., 1989), it is clear that thymocyte-
derived IL-2 is grossly inadequate to drive the
extensive proliferation in this organ.
Our results support the finding that transgenic
mice homozygous for an IL-2 gene disruption
did not make IL-2 and yet generated all major
thymocyte populations in normal numbers
(Schorle et al., 1991). However, the extreme rarity
of IL-2-rich "niches" in the normal adult thymus
raises a caveat about the interpretation of the
gene disruption results. If IL-2 were normally
required as a growth factor for a particular sub-
set of cells in the thymus, then its targets must
represent a very minor fraction of cells in the cor-
tex, the deletion of which might not drastically
affect thymocyte population dynamics as a
whole. Thus, an effect of IL-2 on some minor or
transient branch of the T-cell lineage cannot be
ruled out.
Developmental Significance of IL-2 Induction
In Vivo: IL-2 as an Indicator of a Rare Activation
Event
What may be the most telling aspect of our data
is the access they provide into the intrathymic
activation events that are detected as the induc-
tion of IL-2 gene expression in the murine thy-
mus in vivo. These activation events depend both
on the delivery of the appropriate signal from the
thymic microenvironment and on the develop-
mental status of the responding thymocyte
(Howe and MacDonald, 1988; Rothenberg et al.,
1990; Fischer et al., 1991). Little is known about
the biochemical basis of thymic lymphostromal
interactions, and key events in which activation
signals are delivered have been more commonly
inferred than demonstrated. On the other hand,
the IL-2 induction response in vitro is relatively
well characterized, both in terms of cytoplasmic
signaling cascade and the transcription factors
that are mobilized in the activated cells. Thus,
our results provide strong evidence that this par-
ticular cascade of responses is indeed triggered in
vivo in particular cells in the fetal and postnatal
thymus.
As both immature (TcR-) and mature (TcRhigh)
thymocytes can in principle make IL-2, the intra-
thymic IL-2 production observed could represent
a response either of an immature cell, presum-
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ably to differentiating signals, or of a mature cell
(possibly to antigen). We have utilized two
complementary kinds of evidence to reach a pro-
visional conclusion. One is the intrathymic
location of IL-2-expressing cells: In postnatal
mice, the cortex is a zone of differentiation and
precursor expansion, and the medulla is a
domain where mature thymocytes accumulate
and encounter circulating cells and antigen. The
other relates to the effect of the scid mutation on
intrathymic IL-2 expression. By preventing cor-
rect TcR gene rearrangement, this mutation
blocks all TcR-expression-dependent events in T-
cell development while permitting those that
precede TcR gene rearrangement. The results of
our analysis suggest that both fetal and postnatal
cells that make IL-2 in the thymus are responding
to developmental signals, rather than environ-
mental antigen, but that distinct, nonequivalent
cell types are responding to these signals in the
fetal versus postnatal thymus.
To elaborate, the fetal thymocytes that make
IL-2 are unaffected by the scid mutation, even
though the scid mutation effectively blocks the
generation of fetal TcR/ thymocytes. Therefore,
the activation signal that induces IL-2 expression
in fetal thymocytes is likely to be delivered to
cells at a stage upstream of the scid arrest point,
that is, prior to TcR expression. This interpret-
ation is supported by the failure of IL-2-express-
ing cells to colocalize with TcR-expressing cells
in the day 15 fetal thymus (i.e., V,3+ cells). By
contrast, since the scid mutation does block the
appearance of all IL-2-expressing cells in post-
natal thymus, it is probable that postnatal thymo-
cytes normally receive an IL-2-inducing signal
downstream of the scid arrest point, as discussed
further below. Thus, in the context of their own
developmental lineage, the postnatal IL-2
expressors are likely to be more advanced than
the fetal IL-2 expressors. However, the cortical
location of the postnatal IL-2 producers argues
against any possibility that they have completed
their intrathymic processing. Instead, the signal
that induces IL-2 expression is apparently deliv-
ered while cells are still in the differentiative
domain of the thymus.
Successful induction of IL-2 expression in vivo
indicates not only that. thymocytes have the
capacity to express IL-2 and that the thymic
stroma has the capacity to deliver triggering sig-
nals, but also that the signal is matched to satisfy
the activation requirements for the particular
classes of thymocytes present. The failure of
adult scid thymocytes to activate IL-2 expression
could be caused by defects in any of these
aspects. However, our in vitro studies (Chen and
Rothenberg, 1993; Rothenberg et al., submitted)
clearly show that the scid thymus is significantly
enriched for cells with the competence to express
IL-2, provided that a certain set of triggering con-
ditions are used in vitro. Therefore, either a lack
of inductive signal or a mismatch between the
available signals and the requirements of the
developmentally arrested cells seems to be impli-
cated. One possible explanation for the failure of
cells in the scid adult thymus to express IL-2 in
vivo would be that the scid thymic microenviron-
ment (i.e., the nonlymphoid component of the
thymus) does not develop properly, due to the
lack of feedback interactions from mature thymo-
cytes. Indeed, there is some evidence for architec-
tural abnormality of the scid thymus (Shores et
al., 1990, 1991; van Ewijk, 1991). However, the
main components reported to be reduced or
absent in the scid thymus are medullary epi-
thelium, and as previously noted, the induction
of IL-2 expression that we detect in the normal
postnatal thymus is never associated with the
medulla. Thus, another explanation for the
inability of cells in the scid adult thymus to
express IL-2 in vivo seems more plausible,
namely, that the scid mutation directly prevents
the maturation of thymocytes themselves to the
stage where they can respond to those IL-2
inductive signals generated by the postnatal thy-
mic cortex. In this case, responsiveness to IL-2-
inducing signals in the adult thymus in vivo
would be at least indirectly dependent on suc-
cessful TcR gene rearrangement. Whether the
TcR itself is implicated in the triggering event
remains to be determined. We are currently in
the process of defining the signals that induce IL-
2 gene expression in the postnatal thymus in vivo.
Conclusions
To summarize, our work shows that IL-2 is
expressed in the fetal and adult thymus of nor-
mal mice in vivo. Although the pattern of IL-2
gene expression differs in the fetal versus adult
thymus, IL-2 expression is highly localized dur-
ing both times in development. In the fetal thy-
mus, high expression of IL-2 is synchronous and
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transient. Surprisingly, fetal thymic expression of
IL-2 in vivo is not disrupted by the scid mutation,
suggesting that normal TcR expression is not a
requisite for IL-2 gene expression in the cell types
present in the fetal thymus. On the other hand,
IL-2 gene expression appears to be dependent
upon TcR gene expression in the adult thymus,
because the scid mutation abrogates the appear-
ance of IL-2-expressing cells in the adult thymus.
Finally, our results indicate that IL-2 is available
to cells in highly restricted areas of the thymus
during development. Taken together, this work
implies that TcR-independent and TcR-depen-
dent interactions are made within the thymus at
different stages of development that, in turn, pro-
vide the proper inducing signal(s) in resident
cells for IL-2 expression in vivo. Likewise, differ-
ences between the fetal and postnatal thymic
microenvironments were clearly evident, both in
terms of IL-2 protein content and in terms of the
subsets of thymocytes induced to express IL-2
therein. The nature of the responsive and
responding cells, and the criteria by which they
are distinguished from others in the same stage
of differentiation are intriguing issues for further
investigation.
MATERIALS AND METHODS
Mice
C57BL/6 Tla/ and C.B-17-scid animals were bred
and maintained in our own facility. Thymuses
from embryos at various stages of gestation were
obtained from females using timed matings. The
appearance of a vaginal plug was designated as
day 0 and on this day the females were separated
from the males. Young "adult" animals were
used at 4 weeks of age. All scid animals were
maintained in an Isotec flexible film isolater
(Indianapolis, Indiana) without antibiotic treat-
ment, except those used for timed matings that
were kept outside the isolator.
Removal and Sectioning of Tissues
Fetal thymuses were removed from embryos
every 12 hr on and following day 14 of gestation
(pregnant females were sacrificed at 10:00 A.M.
and 10 P.M.) and were immediately embedded
in Tissue-Tek O.C.T. compound (Miles Inc.,
Kankakee, Illinois). Thymuses removed from
adult animals were frozen in n-pentane/dry ice
and stored at-70C and embedded in O.C.T.
prior to sectioning. For in situ hybridization, 6-8-
/m serial cryosections were collected onto poly-
colysine-coated glass slides, dried briefly, fixed in
freshly made 4% paraformaldehyde in PBS for
1-4 min, rinsed in PBS and stored in 70% ethanol
at 4C. Alternatively, rinsed sections were stored
with desiccant at-70C and transferred to etha-
nol at 4C, 3-7 days prior to hybridization. For
sensitivity controls/hybridization standards, the
murine thymoma EL4 was induced to express IL-
2 by culturing the cells in the presence of the cal-
cium ionophore A23187 (70nM) and phorbol
myristate acetate (PMA; 17 nM, 10 ng/ml) for
5 hr in RPMI 1640 (Irvine Scientific, Santa Ana,
California) based complete medium sup-
plemented with 5% fetal bovine serum (v/v) as
described elsewhere (Chen and Rothenberg,
1993). Following induction, cells were harvested,
mixed with uninduced cells at a known ratio of
induced-to-uninduced cells, embedded in O.C.T.,
sectioned, fixed, and stored accordingly. For
immunofluroescence and immunohistology, 6-8-
/m cryosections were collected onto 3-aminopro-
pyltriethoxysilane (Fluka, Ronkonkoma, New
York) coated slides, air dried for approximately
1 hr, fixed in cold acetone for 10 s and stored
with desiccant at-20C. For activated lymph
node samples, adult mice (8-12 weeks) were
immunized by hind foot pad injection using
Freund’s complete adjuvant. Popliteal, inguinal,
and pericardial lymph nodes were removed 8
days after immunization and tissues were pro-
cessed as described before.
Hybridization Probes
All IL-2 probes used for in situ hybridization
were IL-2 cDNA fragments cloned into the poly-
linker of the pGEM-1 and -2 plasmids (Promega,
Madison, Wisconsin) using standard procedures.
To ensure IL-2-specific hybridization, RNA
probes did not include the CAG-repeat located in
the 5’-region of the IL-2 cDNA. Two IL-2 RNA
probes were used; a 590-nucleotide (nt) probe
gave a strong signal, and a 430-nt AT-rich probe
(contained within the 590-nt probe) gave
extremely low backgrounds. For the 590 nt probe,
a 750-base pair (bp) PstI-AccI fragment derived
from the full-length IL-2 cDNA (DNAX, Palo
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Alto, California) was subcloned into pGEM-1
and -2 (pCmlL2-1, -2). For the 430-nt probe, a
430-bp HindIII-AccI fragment derived from the
same full-length cDNA clone was also subcloned
into pGEM-1 and -2 (pmIL2.3-1,-2; McGuire and
Rothenberg, 1987). The pCmIL-2 plasmids were
linearized with PvuII and the pmIL2.3 plasmids
were linearized with HindIII. The IL-2Rc probes
were derived from two IL-2Rc cDNA fragments
(Miller et al., 1985), a 5’ 410-bp PstI fragment and
an internal 460-bp TaqI-PvuII fragment. Both
were subcloned into pGEM-1 and were lin-
earized with HindIII. 35S-labeled sense or anti-
sense transcripts were synthesized using T7 RNA
polymerase as described previously (McGuire
and Rothenberg, 1987; McGuire et al., 1988).
Transcription products were resuspended in
200/fl of 100 mM DTT and 0.1% SDS in 10 mM
Tris, 1 mM EDTA, pH 7.4, and stored at-70C
prior to use. All steps in the procedure were car-
ried out using solutions made with diethylpyro-
carbonate-treated water and RNase-free glass-
and plasticware.
In Situ Hybridization
For each in situ hybridization experiment, alter-
nate serial sections were hybridized with anti-
sense and sense (negative control, "NC" in
figures) riboprobes. Cells were only considered
positive where the signal with the antisense
probe clearly exceeded the sense-strand back-
ground. Hybridization was carried out with
modifications to a protocol described previously
(Rothenberg et al., 1990). The hybridization
buffer described previously was modified by the
addition of 4 mM vanadyl ribonucleoside com-
plexes, and hybridization was carried out for
8-12hr. Following hybridization, cover slips
were soaked off in 4xSSC. Unhybridized probe
was removed with three washes in 50% formam-
ide, 2xSSC, 10 mM DTT, and 1% 2-ME at 50C
(1 hr each). Slides were briefly rinsed in 2xSSC,
transferred to digestion buffer (0.5M NaC1,
10 mM Tris-HC1, pH 7.4, 1 mM EDTA) containing
40/g/ml RNase A and 40 U/ml RNase T1 and
digested at 37C for 30 min, after which slides
were transferred to digestion buffer with 20 mM
DTT and 1% 2-ME and incubated at 37C for an
additional 30min. Slides were subsequently
washed overnight in 50% formamide, 2xSSC,
10 mM DTT, 1% 2-ME at 45C and/or in 2xSSC,
1 mM DTT, 1% 2-ME at 45C for 30 min. In each
case, the final wash was in 0.1xSSC, 0.1% 2-ME at
room temperature for 20 min. Slides were dehy-
drated in 30, 50, 70, and 95% ethanol containing
0.3 M ammonium acetate, dried for 1 hr and
dipped in NTB-2 emulsion (Eastman Kodak Co.,
Rochester, New York) diluted at a ratio of 2 to 1
with 0.9M ammonium acetate. Slides were
exposed for 12-21 days, developed at 13C for
3 min in GBX developer (Eastman Kodak Co.),
briefly rinsed in 2% acetic acid, and fixed for
7min in Ektaflo fixer (Eastman Kodak Co.).
Counterstaining was done with 250/g/ml 4,6-
diamidino-2-phenylindole (DAPI) at room tem-
perature for 1-2hr or with hematoxylin and
eosin for 2 min and cover slips were mounted
using Permount (Fisher Scientific, Fair Lawn,
New Jersey). Dual dark field and fluorescence
microscopy were used for analysis.
Antibodies
The rat anti-mouse IL-2 mAb, $4B6, was obtained
commercially at a concentration of l mg/ml
(Pharmingen, San Diego). Normal rat IgG was
reconstituted at a concentration of 20mg/ml
(Miles Inc., Kankakee, Illinois). Immunoselect
phycoerythrin (PE)-conjugated rat anti-mouse
CD25 was purchased from Gibco BRL
(Gaithersburg, Maryland), and biotinylated ham-
ster anti-mouse CD3e (145-2Cll) and fluorescein
(FITC)-conjugated V7/3 TcR (536) mAbs were pur-
chased from Pharmingen. Biotinylated rabbit
anti-rat IgG or goat anti-hamster IgG (both
mouse-absorbed) were obtained from Vector
(Burlingame, California) or CALTAG Labora-
tories (San Francisco), respectively. The
hybridoma 2.4G2 (rat anti-mouse CD16;
FcRII/III) was grown in Fetal Clone II (Hyclone
Sterile Systems, Logan, Utah) and pooled culture
supernatants were used neat for staining.
Immunohistochemistry
The immunohistochemical staining protocol was
adapted from procedures described by Farr et al.
(1990) and Bogen et al. (1991). Sections were
warmed to room temperature, fixed in cold ace-
tone for an additional 2 min, transferred to 1%
formaldehyde in PBS for 1 min, and washed in
PBS for 5 min. Sections were blocked with 50
btg/ml avidin in PBS, followed by treatment with
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250/g/ml D-biotin in PBS, each for 20 min. Sec-
tions were then washed in PBS/0.025% sodium
azide (NaN3) and incubated with 2% normal
mouse serum (Cappel/Organon Teknika Co.,
Durham, North Carolina) and 2% normal rabbit
serum in PBS/1% BSA/0.025% NaN3 in a
humidified chamber at room temperature for
30 min. After every subsequent incubation, sec-
tions were washed with PBS/NaN3. Following
blocking steps, sections were incubated with 10
/tg/ml primary antibody or normal rat IgG in
PBS/BSA/NaN3 at room temperature for 1 hr.
Sections were then incubated with 10 tg/ml bio-
tinylated secondary staining reagent (mouse
absorbed) in PBS/BSA/NaN3 at room tempera-
ture for an additional hour. Subsequently, sec-
tions were refixed in 2% paraformaldehyde in
PBS for 10 min and quenched with 0.6% H202 in
methanol for 15 min. Following extensive wash-
ing in PBS, staining was detected using an
avidin-biotin-horseradish peroxidase complex
(Vectastain Elite ABC; Vector Laboratories) and
diaminobenzidine (DAB) as the enzymatic sub-
strate (as described in the Vectastain protocol).
Blocking experiments were performed using
recombinant murine IL-2 or IL-4 purchased from
Genzyme (Boston) and were carried out by pre-
incubating the primary antibody with an excess
of recombinant lymphokine (1000 U/ml) at room
temperature for at least 1 hr prior to staining.
Nickel/cobalt-enhanced staining was achieved
using 30 mg NiC12 and 30 mg COC12 per 10 ml
DAB: H202 developing solution.
Ribonuclease Probe Protection
Total RNA from samples containing known per-
centages of induced and uninduced EL4 was iso-
lated using the technique published by Chom-
czynski and Sacchi (1987). Probe-protection
measurements of IL-2 mRNA using the 430-nt IL-
2 probe have been described elsewhere (McGuire
and Rothenberg, 1987; McGuire et al., 1988). The
average number of molecules per cell was deter-
mined using a Phosphor Imager (Molecular
Dynamics, Sunnyvale, California) and assuming
complete recovery of protected products from
each sample of 106 cell equivalents. The sensi-
tivity of this technique was 0.2 copies per cell (or
a total of lx105 copies per RNA sample isolated
from 106 cells; data not shown), and no IL-2
mRNA was detected in uninduced samples.
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Direct Immunofluorescence
Staining procedure was modified from a protocol
provided by Calbiochem (La Jolla, California).
Sections were warmed to room temperature,
fixed in cold acetone and briefly in 1% formal-
dehyde in PBS, and washed in PBS. Sections were
then blocked with 2% normal mouse serum in
PBS/BSA/NaN3. Following a PBS/NaN3 wash,
sections were incubated with 6-10/g/ml pri-
mary antibody in PBS/BSA/NaN3 in a humidi-
fied chamber for 1 hr. Sections were washed
again with PBS/Na azide. Stained sections were
covered with 2-4 drops of Fluorosave Reagent
(Calbiochem, La Jolla) and cover slips were
mounted and sealed with clear nail polish.
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